Efforts to share the news of Greater Philadelphia as an epicenter of cell and gene therapy and connected health are in full force.
The local organizations join a collaboration funded by the Coalition for Epidemic Preparedness Innovations (CEPI) to accelerate the development of vaccines against emerging infectious diseases and enable equitable access to the vaccines during outbreaks.
The Philadelphia Alliance for Capital and Technologies released its 2019 Philadelphia Venture Report, placing Philadelphia in the top 10 VC markets in the United States. Utilizing research from PitchBook, the report covers VC investments by industry and includes the pharma and biotech sectors in addition to other industries.
A collaboration commissioned a research study to assess the workforce and talent needs of the cell and gene therapy and connected health industries in the Greater Philadelphia region.
According to the recently released Q4 2019 Healthcare MoneyTree™ Report, the Biotechnology subsector led the Healthcare industry in the fourth quarter in terms of dollars invested, raising $2.4 billion.
Big4Bio, which added Philadelphia to their geographic coverage areas in June 2019, recently debuted it first Year in Review report for our region.
Amicus Therapeutics recently opened its new Global Research & Gene Therapy Center of Excellence at 3675 Market Street in Philadelphia.
More than 9,000 attendees from across the globe, including industry leaders, emerging fast-growth companies, technology creators, and investors, are expected.
ChristianaCare’s Gene Editing Institute, located in Newark, Delaware, recently announced an innovation that could accelerate CRISPR gene editing work.
The Greater Philadelphia region’s health care and life sciences community has much to celebrate as 2019 concludes.
